Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Must-See Moments at HIMSS 2019

The Healthcare Information and Management Systems Society (HIMSS) is holding its industry-leading health information and technology conference Feb. 11-15 in Orlando, Florida. More than 45,000 healthcare professionals and thought leaders are expected at this year’s event— it assuredly will not disappoint. Health care is changing rapidly and with it the methods and practices used in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The Healthcare Information and Management Systems Society (HIMSS) is holding its industry-leading health information and technology conference Feb. 11-15 in Orlando, Florida. More than 45,000 healthcare professionals and thought leaders are expected at this year’s event— it assuredly will not disappoint.

Health care is changing rapidly and with it the methods and practices used in the industry are as well. Speaking with Senior Director of Strategic Communications for HIMSS Karen Groppe, MarketScale got an inside look into what to watch for, who to see, and just how advanced healthcare is entering 2019.

Will Consumer-Directed Exchange Disrupt the Healthcare Marketplace: A Keynote Speech

President and CEO of HIMSS Hal Wolf III will be moderate the opening keynote session of the event, a discussion among a world-renowned panel of both industry experts and government officials.

The group includes the likes of former Utah Governor and former HHS Secretary Michael Leavitt, former US Chief Technology Officer Aneesh Chopra, former National Coordinator for Health IT Karen DeSalvo and more.

The topics at hand will primarily revolve around the rise of consumer-directed exchanges and patient-friendly advancements in technology while addressing the policy changes and market-disruption that go along with this new frontier of high-tech patient-care.

Cybersecurity Panels

In an era of data breaches and cyberattacks across industries worldwide, even the healthcare sector is not immune.

According to Groppe, the “Defeat Nation-State Actors Stalking the Healthcare Sector” session will feature “Retired Brigadier General Greg Touhill, the first Chief Information Security Officer of the United States government and current president of the Cyxtera Federal Group, discussing the current cyber threat environment; the tactics, techniques, and procedures used by nation state actors and cyber-criminal groups to threaten organizations; why the health care environment is at high risk; and what the health care sector should do to better manage their risk.”

Opioid Crisis and Population Health

The opioid epidemic in the US reached startling levels over the last year and the health care industry is taking serious steps to mitigate the damage and utilize technology to prevent a crisis like this from ever reaching these proportions again.

For those interested in this topic, attendees should be sure to visit “A Quality and Analytics-Based Approach to the Opioid Epidemic” according to Groppe.

This session is set to “explore how can we use technology to support providers in promoting better, safer patient care, empower them to be compliant with regulatory requirements and ease the administrative burden they feel when trying to provide care for these complex patients.”

Senior Care

“The Silver Tsunami”, as Groppe put it, is a facetious but accurate take on the issue of a growing population of elderly patients that will require care.

An estimated 11,000 people per day in the U.S. are reaching 65 years of age, with increasingly complex and chronic care needs. Health care expenditures are continuing to considerably outpace GDP growth. Organizations are coping with these rising costs by consolidating to gain economies of scale, but this impacts competition and choice.”

The “Healthy Aging and Technology Symposium: Building a Digital Bridge to Transform the Aging Experience” session will address issues like “continuity of care for chronic conditions, social isolation, loneliness and medication management through information and technology can transform health and wellness in aging while also meeting caregiver needs.”

The health care industry is undergoing a complete transformation with the continued advancement and integration of new technologies in the workplace. Whether it is patient-care or cybersecurity, this year’s HIMSS conference will leave attendees with something new, and undoubted optimism for the future of healthcare in the United States.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512